Nanobiotix (NBTX)
(Delayed Data from NSDQ)
$7.38 USD
+0.19 (2.64%)
Updated Aug 8, 2025 03:59 PM ET
3-Hold of 5 3
F Value A Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NBTX 7.38 +0.19(2.64%)
Will NBTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NBTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NBTX
Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study
NBTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NBTX
Nanobiotix (NBTX) Trading Resumes, Investors Eye Future Moves | NBTX Stock News
Nanobiotix (NBTX) Trading Temporarily Halted Due to Volatility | NBTX Stock News
Nanobiotix SA - ADR trading resumes
Nanobiotix SA - ADR trading halted, volatility trading pause
Nanobiotix Advances JNJ-1900 with Regulatory and Patent Milestones